Contact Pharmxen LLC
Get a real-time quoteYour healthcare market-entry partner in the EAEU
Pharmxen helps healthcare companies enter and expand across the Eurasian Economic Union (EAEU). We develop and execute market-entry strategies for finished pharmaceutical products, medical devices, food supplements and cosmetics, supporting projects from opportunity assessment to commercial launch.
Our services include:
• Market assessment, competitor analysis and market-entry strategy
• Licensing partner and distributor search, qualification and engagement
• Business case development and commercial negotiation support
• Technology transfer readiness assessment and project coordination
• Go-to-market planning, distribution and launch support
Our team brings together more than a decade of pharmaceutical business development experience, medical-advisory expertise and over 20 years of commercial experience. We combine product assessment, partnership development and local market knowledge to build commercially viable routes to market.
Working with partners worldwide and a network of pharmaceutical companies and distributors across the EAEU, we help product owners establish local partnerships and support regional companies in expanding their portfolios.
-
Min project size
$1,000+
-
Hourly rate
$200 - $300 / hr
-
Employees
2 - 9
-
Year founded
Founded 2024
Service Lines
- Market Research
- 35%
- Manufacturing Consulting
- 10%
- Procurement Support
- 5%
No Focus Areas have been added yet…
Industries
- Medical
- 100%
Clients
No Clients have been added yet…
Have you worked with Pharmxen LLC?
Share your experience working with Pharmxen LLC on a past project by leaving a review for buyers around the world
Contact Pharmxen LLC
If you’re not seeing exactly what you need here, send this company a custom message. You can talk about your project needs, price, and timeline to get started on your project.
Sign in to see which brands trust Pharmxen LLC.
Get connected to see updates from Pharmxen LLC like new case studies, latest reviews, their latest masterpieces in their portfolio, delivered straight to you.